Verici Dx plc (AIM:VRCI)
London
· Delayed Price · Currency is GBP · Price in GBX 1.785
-0.090 (-4.80%)
Apr 25, 2025, 4:17 PM GMT+1
Verici Dx Market Cap
Verici Dx has a market cap or net worth of 4.55 million as of April 25, 2025. Its market cap has decreased by -76.56% in one year.
Market Cap
4.55M
Enterprise Value
-640.71K
Revenue
3.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.79
Market Cap Chart
Since November 3, 2020, Verici Dx's market cap has decreased from 51.74M to 4.55M, a decrease of -91.21%. That is a compound annual growth rate of -41.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 4.55M | -51.61% |
| Dec 31, 2024 | 9.40M | -43.40% |
| Dec 29, 2023 | 16.61M | -22.00% |
| Dec 30, 2022 | 21.29M | -71.66% |
| Dec 31, 2021 | 75.13M | -9.40% |
| Dec 31, 2020 | 82.92M | 60.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.48B |
| Haleon | 33.98B |
| Smith & Nephew | 8.79B |
| ConvaTec Group | 5.28B |
| Hikma Pharmaceuticals | 4.24B |
| HUTCHMED (China) | 2.03B |
| Oxford Nanopore Technologies | 1.14B |